Inventor · disambiguated record
Andreas Kuhn
Also filed as: KUHN ANDREAS
9 granted patents·7 pending applications·50 citations·filing 2010–2025
85Inventor score
Top patents by PatentIndex Score
16 records- 0194US11547673B1Coronavirus vaccineBioNTech SE·Filed 2021·Granted Jan 10, 2023·12 cites·45 claims
- 0293US10717982B2Stabilization of poly(A) sequence encoding DNA sequencesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Jul 21, 2020·18 cites·19 claims
- 0392US9295717B2Vaccine composition comprising 5′-cap modified RNASAHIN UGUR·Filed 2010·Granted Mar 29, 2016·18 cites·16 claims
- 0489US11925694B2Coronavirus vaccineBioNTech SE·Filed 2022·Granted Mar 12, 2024·1 cites·36 claims
- 0586US2025242059A1Coronavirus vaccineBioNTech SE·Filed 2024·Application pending·0 cites
- 0681US12133899B2Coronavirus vaccineBioNTech SE·Filed 2022·Granted Nov 5, 2024·0 cites·24 claims
- 0780US2025011797A1Stabilization of poly(a) sequence encoding dna sequencesBioNTech SE·Filed 2024·Application pending·0 cites
- 0871US11492628B23′-UTR sequences for stabilization of RNABioNTech SE·Filed 2016·Granted Nov 8, 2022·1 cites·73 claims
- 0966US12054723B2Stabilization of poly(A) sequence encoding DNA sequencesBioNTech SE·Filed 2020·Granted Aug 6, 2024·0 cites·16 claims
- 1061US12305210B2In vitro transcription technologiesBioNTech SE·Filed 2022·Granted May 20, 2025·0 cites·18 claims
- 1160US12281138B25′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Apr 22, 2025·0 cites·69 claims
- 1259US2021340170A15'-cap compounds and their uses in stabilizing rna, expressing proteins and in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1355US2025388944A1In vitro transcription technologiesBioNTech SE·Filed 2025·Application pending·0 cites
- 1450US2024110214A1Rna manufacturingBioNTech SE·Filed 2021·Application pending·0 cites
- 1546US2024002127A1Coronavirus vaccinePFIZER·Filed 2021·Application pending·0 cites
- 1643US2020362313A1Method of enhancing rna expression in a cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Kuhn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →